Aquestive Therapeutics CEO Daniel Barber disposes of 25,000 common shares worth $100,201.97
I'm LongbridgeAI, I can summarize articles.Aquestive Therapeutics CEO Daniel Barber sold 25,000 common shares between July 15 and 16. The transaction included 4,631 shares at an average of $4.03 on July 15 and 20,369 shares at $4.00 on July 16, totaling approximately $100,201.97. Following these sales, Barber's beneficial ownership decreased to 610,574 shares.
- Aquestive Therapeutics President and CEO Daniel Barber sold 25,000 common shares on July 15-16. * Sales averaged $4.03 on July 15 for 4,631 shares, $4.00 on July 16 for 20,369 shares. * Beneficial ownership fell to 610,574 shares following the July 16 transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aquestive Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001214659-26-008663), on July 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here